Exercise of the over-Allotment Option in Attendo

Regulatory News

Carnegie and SEB ("Joint Global Coordinators”) have today notified Attendo AB (publ) ("Attendo” or the "Company”) (STO:ATT) and Augustus International S.á r.l (the "Principal Shareholder”) (which is owned by the IK 2004 Fund and its co-investors) that the over-allotment option has been exercised in full in respect of 8,664,000 shares in Attendo.

In connection with the initial public offering of Attendo, the Principal Shareholder granted the Joint Global Coordinators an over-allotment option of up to 8,664,000 shares to be used to cover over-allotment of shares. The Joint Global Coordinators have today exercised the over-allotment option in full. No stabilisation has been carried out since the listing, and as a result of Attendo’s share price development, the Joint Global Coordinators have decided to end the stabilisation period.

Following the exercise of the over-allotment option, the Principal Shareholder holds 29,290,636 shares in Attendo, corresponding to approximately 18.3 percent of the total number of shares in Attendo.

About Attendo

Attendo is the leading care provider in the Nordics. The Company conducts operations in Sweden, Finland, Norway and Denmark. Attendo is the largest private company within care for older people in Sweden and Finland and also within publicly financed healthcare in Finland. Attendo is locally established and has approximately 490 operations located in more than 200 municipalities. The Company has more than 18,000 employees. With the vision to empower the individual, Attendo conducts operations within care for older people, care for people with disabilities, individual and family care and healthcare.

Attendo was incorporated in 1985 and in 1988 Attendo received Sweden’s first outsourcing agreement within home care in Danderyd, Stockholm. Since then, more municipalities have chosen to open up publicly financed care in order to achieve increased freedom of choice and competition, inter alia, in order to promote quality development. For more information, about Attendo visit www.attendo.com.

Important information

This announcement is not and does not form a part of any offer to sell, or a solicitation of an offer to purchase, any securities of the Company.

Copies of this announcement are not being made and may not be distributed or sent into the United States, Australia, Canada, Japan or any other jurisdiction in which such distribution would be unlawful or would require registration or other measures.

These materials are not an offer for sale of securities in the United States. Securities may not be sold in the United States absent registration with the United States Securities and Exchange Commission or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "Securities Act”). The Company does not intend to register any part of the offering in the United States or to conduct a public offering of the shares in the United States. Any securities sold in the United States will be sold only to qualified institutional buyers (as defined in Rule 144A under the Securities Act) pursuant to Rule 144A.

This announcement is an advertisement and is not a prospectus for the purposes of the Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive”). A prospectus prepared pursuant to the Prospectus Directive will be published, which, when published, can be obtained from the Company. Investors should not subscribe for any securities referred to in this announcement except on the basis of information contained in the prospectus.

In any EEA Member State other than Sweden that has implemented the Prospectus Directive, this communication is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive, i.e., only to investors who can participate in the Offering without an approved prospectus in such EEA Member State.

This announcement is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order”) or (iii) high net worth companies, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons in (i), (ii) and (iii) above together being referred to as "relevant persons”). The shares are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. Any person who is not a relevant person should not act or rely on this announcement or any of its contents.

Matters discussed in this announcement may constitute forward-looking statements. Forward-looking statements refer to statements which do not refer to historical facts and events, and statements which are attributable to the future, such as expressions as "deem”, "assess”, "expect”, "await”, "judge”, "assume”, "predict”, "can”, "will”, "shall”, "should or ought to”, "according to estimates”, "consider”, "may”, "plan”, "potential”, "calculate”, "as far as is known” or similar expressions suitable for identifying information that refers to future events. This applies in particular to statements referring to future results, financial position, cash flow, plans and expectations for the Company’s business and management, future growth and profitability and general economic and regulatory environment and other circumstances which affect the Company. Forward-looking statements are based on current estimates and assumptions which are based on the Company’s current intelligence. Such future looking statements are subject to risks, uncertainties and other factors which may result in actual results, including the Company’s financial position, cash flow and profits, deviating considerably from the results which expressly or indirectly form the basis of, or are described in, statements, or may result in the expectations which, expressly or indirectly, form the basis of or are described in statements not being met or turning out to be less advantageous compared to the results, which expressly or indirectly formed the basis of or were described in the statements. The Company’s business is exposed to a number of risks and uncertainties which may result in forward-looking statements being inaccurate or an estimate or calculation being incorrect. Therefore, potential investors should not place undue reliance on the forward-looking statements herein and are strongly advised to read detailed description of factors which have an effect on the Company’s business and the market in which the Company operates that will be included in the prospectus.

The information, opinions and forward-looking statements contained in this announcement speak only as at its date, and are subject to change without notice.

This information was brought to you by Cision http://news.cision.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20151210006682/en/